How to switch a patient from Lexapro (escitalopram) 20 mg daily to Zoloft (sertraline)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switching from Lexapro 20 mg to Zoloft

For a patient on escitalopram (Lexapro) 20 mg daily switching to sertraline (Zoloft), perform a direct switch by stopping escitalopram and starting sertraline 50 mg the next day, as both are SSRIs with similar mechanisms and no washout period is required. 1

Switching Strategy

Direct Switch Approach

  • Stop escitalopram 20 mg and start sertraline 50 mg the following day 1, 2
  • Direct switching between SSRIs is well-tolerated and avoids the risk of untreated depression during a washout period 1
  • No tapering of escitalopram is necessary when switching to another SSRI, as both medications work through similar serotonergic mechanisms 2

Rationale for Direct Switch

  • Escitalopram has negligible effects on cytochrome P450 enzymes and low drug interaction potential, making direct switching safe 3
  • The conservative approach (gradual taper with washout) takes longer and includes periods without treatment, risking life-threatening exacerbations of depression 1
  • Direct switching is easier and avoids compliance issues associated with complex tapering schedules 4

Sertraline Dosing

Initial Dose

  • Start sertraline at 50 mg daily 2
  • This is the standard starting dose for adults switching from another antidepressant 2

Dose Titration

  • If inadequate response after 4 weeks, increase sertraline to 100 mg daily 3, 4
  • Maximum dose of sertraline is 200 mg daily if needed for treatment response 2
  • Increase in 50 mg increments every 1-2 weeks based on tolerability and response 2

Monitoring Protocol

Early Follow-up

  • Contact patient within 1 week to assess tolerability and adherence 3
  • Monitor for new or worsening side effects during the transition 1
  • Watch for signs of serotonin syndrome, though risk is low with SSRI-to-SSRI switches 3

Response Assessment

  • Assess treatment response at 4 weeks 3, 4
  • If response is inadequate at 4 weeks, consider dose escalation 3
  • Full therapeutic effect may take 6-8 weeks 4

Important Caveats

What NOT to Do

  • Do not combine escitalopram and sertraline - there is no indication for co-administration and this increases serotonin syndrome risk 1
  • Do not use a washout period between these two SSRIs - this is only necessary when switching to/from MAOIs 2
  • Do not taper escitalopram unless the patient has been on it for many years at high doses and you're concerned about discontinuation symptoms 1

Discontinuation Symptoms

  • While direct switching minimizes risk, some patients may experience mild discontinuation symptoms from escitalopram (dizziness, headache, irritability) 1
  • These typically resolve within days as sertraline reaches therapeutic levels 1
  • If discontinuation symptoms are severe, consider briefly overlapping medications for 3-5 days, though this is rarely necessary 2

When to Use Alternative Strategies

  • If the patient is on other serotonergic medications (triptans, tramadol, other antidepressants), exercise additional caution and monitor closely for serotonin syndrome 3
  • For patients with history of severe discontinuation symptoms from prior antidepressant switches, consider a brief 3-5 day cross-taper 2

References

Research

Switching and stopping antidepressants.

Australian prescriber, 2016

Guideline

Direct Switch from Citalopram to Escitalopram

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.